Introduction: The aim of this study was to compare the safety of ultrasonography-guided (UG) puncture and fluoroscopy-guided (FG) upper pole access (UPA) in percutaneous nephrolithotomy (PCNL). Methods: Consecutive patients with a solitary UPA were enrolled into the study from 2012 to 2020 and analyzed in a retrospective manner. In total, 177 patients were divided into 2 groups according to the method during the puncture phase of the access: FG (n = 105) and UG (n = 72). The UG and FG groups were compared in terms of complications (i.e., pleural injury and blood transfusion rate) and surgical outcomes. Results: Gender, side, grade of hydronephrosis, type of access (i.e., supracostal vs. subcostal), Guy’s stone score, age, stone diameter, skin-to-stone distance, and stone density were similar in the 2 groups (p > 0.05). Only in 25.9% of cases, UPA was done using a subcostal approach. The overall complication rates were similar between the groups (p > 0.178). For the UG and FG groups, the rate of pleural injury (8.5 vs. 4.1%) and the blood transfusion rate (8.5 vs. 2.8%) were also similar (p > 0.05). The fluoroscopy time and mean hemoglobin drop were significantly lower in the UG group than in the FG group (134.2 vs. 82.2 s, respectively, p = 0.001; 20.8 ± 9.8 vs. 16.8 ± 7.9 g/L, respectively, p = 0.001). Stone-free rate (SFR) was also similar in the FG and UG groups (77.1 vs. 75.0%, respectively, p = 0.742). Conclusion: While it is commonly expected that the complication rates are lower in UG puncture for UPA in PCNL than they are in FG puncture, the present study failed to show this difference. However, the radiation exposure time seemed to be lower in UG puncture than FG puncture and had a similar stone-free rate (SFR) for UPA in PCNL.

1.
Türk
C
,
Petřík
A
,
Sarica
K
,
Seitz
C
,
Skolarikos
A
,
Straub
M
, et al.
EAU guidelines on interventional treatment for urolithiasis
.
Eur Urol
.
2016 Mar
;
69
(
3
):
475
82
.
2.
Munver
R
,
Delvecchio
FC
,
Newman
GE
,
Preminger
GM
.
Critical analysis of supracostal access for percutaneous renal surgery
.
J Urol
.
2001 Oct
;
166
(
4
):
1242
6
.
3.
Kim
SC
,
Kuo
RL
,
Lingeman
JE
.
Percutaneous nephrolithotomy: an update
.
Curr Opin Urol
.
2003 May
;
13
(
3
):
235
41
.
4.
Pedro
RN
,
Netto
NR
.
Upper-pole access for percutaneous nephrolithotomy
.
J Endourol
.
2009 Oct
;
23
(
10
):
1645
7
.
5.
El-Karamany
T
.
A supracostal approach for percutaneous nephrolithotomy of staghorn calculi: a prospective study and review of previous reports
.
Arab J Urol
.
2012 Dec
;
10
(
4
):
358
66
.
6.
de la Rosette
J
,
Assimos
D
,
Desai
M
,
Gutierrez
J
,
Lingeman
J
,
Scarpa
R
, et al.
The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients
.
J Endourol
.
2011 Jan
;
25
(
1
):
11
7
.
7.
Wang
K
,
Zhang
P
,
Xu
X
,
Fan
M
.
Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a meta-analysis
.
Urol Int
.
2015
;
95
(
1
):
15
25
.
8.
Ng
FC
,
Yam
WL
,
Lim
TYB
,
Teo
JK
,
Ng
KK
,
Lim
SK
.
Ultrasound-guided percutaneous nephrolithotomy: advantages and limitations
.
Investig Clin Urol
.
2017 Sep
;
58
(
5
):
346
52
.
9.
Thomas
K
,
Smith
NC
,
Hegarty
N
,
Glass
JM
.
The Guy’s stone score: grading the complexity of percutaneous nephrolithotomy procedures
.
Urology
.
2011 Aug
;
78
(
2
):
277
81
.
10.
Tanidir
Y
,
Sahan
A
,
Asutay
MK
,
Sener
TE
,
Talibzade
F
,
Garayev
A
, et al.
Differentiation of ureteral stones and phleboliths using Hounsfield units on computerized tomography: a new method without observer bias
.
Urolithiasis
.
2017 Jun
;
45
(
3
):
323
8
.
11.
Simon
GI
,
Craswell
A
,
Thom
O
,
Fung
YL
.
Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis
.
Lancet Haematol
.
2017 Oct
;
4
(
10
):
e465
74
.
12.
Yang
YH
,
Wen
YC
,
Chen
KC
,
Chen
C
.
Ultrasound-guided versus fluoroscopy-guided percutaneous nephrolithotomy: a systematic review and meta-analysis
.
World J Urol
.
2019 May
;
37
(
5
):
777
88
.
13.
Clavien
PA
,
Barkun
J
,
de Oliveira
ML
,
Vauthey
JN
,
Dindo
D
,
Schulick
RD
, et al.
The Clavien-Dindo classification of surgical complications: five-year experience
.
Ann Surg
.
2009 Aug
;
250
(
2
):
187
96
.
14.
Soares
RMO
,
Zhu
A
,
Talati
VM
,
Nadler
RB
.
Upper pole access for prone percutaneous nephrolithotomy: advantage or risk?
Urology
.
2019 Dec
;
134
:
66
71
.
15.
Mousavi-Bahar
SH
,
Mehrabi
S
,
Moslemi
MK
.
The safety and efficacy of PCNL with supracostal approach in the treatment of renal stones
.
Int Urol Nephrol
.
2011 Dec
;
43
(
4
):
983
7
.
16.
Singh
R
,
Kankalia
SP
,
Sabale
V
,
Satav
V
,
Mane
D
,
Mulay
A
, et al.
Comparative evaluation of upper versus lower calyceal approach in percutaneous nephrolithotomy for managing complex renal calculi
.
Urol Ann
.
2015 Jan–Mar
;
7
(
1
):
31
5
.
17.
Andonian
S
,
Scoffone
CM
,
Louie
MK
,
Gross
AJ
,
Grabe
M
,
Daels
FP
, et al.
Does imaging modality used for percutaneous renal access make a difference? A matched case analysis
.
J Endourol
.
2013 Jan
;
27
(
1
):
24
8
.
18.
Tefekli
A
,
Esen
T
,
Olbert
PJ
,
Tolley
D
,
Nadler
RB
,
Sun
YH
, et al.
Isolated upper pole access in percutaneous nephrolithotomy: a large-scale analysis from the CROES percutaneous nephrolithotomy global study
.
J Urol
.
2013 Feb
;
189
(
2
):
568
73
.
19.
Patel
AP
,
Bui
D
,
Pattaras
J
,
Ogan
K
.
Upper pole urologist-obtained percutaneous renal access for PCNL is safe and efficacious
.
Can J Urol
.
2017 Apr
;
24
(
2
):
8754
8
.
20.
Kekre
NS
,
Gopalakrishnan
GG
,
Gupta
GG
,
Abraham
BN
,
Sharma
E
.
Supracostal approach in percutaneous nephrolithotomy: experience with 102 cases
.
J Endourol
.
2001 Oct
;
15
(
8
):
789
91
.
21.
Sourial
MW
,
Francois
N
,
Box
GN
,
Knudsen
BE
.
Supracostal access tubeless percutaneous nephrolithotomy: minimizing complications
.
World J Urol
.
2019 Jul
;
37
(
7
):
1429
33
.
22.
Li
J
,
Xiao
B
,
Hu
W
,
Yang
B
,
Chen
L
,
Hu
H
, et al.
Complication and safety of ultrasound guided percutaneous nephrolithotomy in 8,025 cases in China
.
Chin Med J
.
2014
;
127
(
24
):
4184
9
.
23.
Gupta
R
,
Kumar
A
,
Kapoor
R
,
Srivastava
A
,
Mandhani
A
.
Prospective evaluation of safety and efficacy of the supracostal approach for percutaneous nephrolithotomy
.
BJU Int
.
2002 Dec
;
90
(
9
):
809
13
.
24.
Golab
A
,
Smektala
T
,
Krolikowski
M
,
Slojewski
M
.
Percutaneous nephrolithotomy using an individual 3-dimensionally printed surgical guide
.
Urol Int
.
2018
;
100
(
4
):
485
7
.
25.
Sampaio
FJ
,
Zanier
JF
,
Aragão
AH
,
Favorito
LA
.
Intrarenal access: 3-dimensional anatomical study
.
J Urol
.
1992 Dec
;
148
(
6
):
1769
73
.
26.
Chi
T
,
Masic
S
,
Li
J
,
Usawachintachit
M
.
Ultrasound guidance for renal tract access and dilation reduces radiation exposure during percutaneous nephrolithotomy
.
Adv Urol
.
2016
;
2016
:
3840697
.
27.
Basiri
A
,
Kashi
AH
,
Zeinali
M
,
Nasiri
M
,
Sarhangnejad
R
,
Valipour
R
.
Ultrasound: guided access during percutaneous nephrolithotomy: entering desired calyx with appropriate entry site and angle
.
Int Braz J Urol
.
2016 Nov–Dec
;
42
(
6
):
1160
7
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.